Jiangsu Hengrui Medicine buys back shares for employee stock plan

Jiangsu Hengrui Medicine (SSE:600276) executed a share repurchase on October 20, 2025, buying back 10,000 A-shares on the Shanghai Stock Exchange. The repurchase was conducted at RMB 65 per share, totaling RMB 650,000. These shares are intended to be held as treasury stock for an A-share employee stock ownership plan.

The transaction resulted in a slight increase in treasury shares from 14,703,610 to 14,713,610. The number of outstanding shares (excluding treasury shares) decreased by 10,000 to 6,364,288,664. This change represents a 0.0002% reduction in the company's issued shares (excluding treasury shares) compared to the balance as of October 17, 2025. The total number of issued shares remains 6,379,002,274.